<?xml version="1.0" encoding="UTF-8" standalone="yes"?><getRegulatorySnapshotOutput id="52700"><Title>Congressional Testimony: Richard Pazdur, M.D., CDER, on "Women and Cancer: Where Are We in Prevention, Early Detection and Treatment of Gynecologic Cancers?", 07-Sep-2005</Title><Versions><Version>Final</Version></Versions><Status>Valid</Status><Abstract>This testimony summarizes the recent FDA actions in order to improve oncologic drugs research: specific review processes to speed the development and approval of anti-cancer drugs (accelerated approval, priority review, fast track designation), specific workshop on endpoints related to various cancers, creation of an Interagency Oncology Task Force,...</Abstract><Region>USA</Region><Languages><language>English</language></Languages><Number>52700</Number><DocCategories><DocCategory>Reference Document</DocCategory></DocCategories><ProdCategories><ProdCategory>Drugs and Biologics</ProdCategory></ProdCategories><DocTypes><DocType>Testimony</DocType></DocTypes><Source>Obtained from the FDA website.&lt;br/&gt;www.fda.gov&lt;br/&gt;07-SEP-2005</Source><DateDisplay>7-Sep-2005</DateDisplay><DocForm>0</DocForm><AddedDate>14-Sep-2005</AddedDate><LastUpdatedDate>31-May-2012 11:47:00</LastUpdatedDate><Topics/><MedicalDeviceSpecialties/></getRegulatorySnapshotOutput>